CDH5 and Alzheimer disease: Reduction in VE-cadherin expression resulting in BBB disruption at post-capillary venules occurs in neurodegenerative disorders, such as Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis, and multiple sclerosis2, 3, 4, 5.